Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07308704 · ClinicalTrials.gov registry record
A Study Of Deep Learning For Echo Analysis, Tracking, And Evaluation
A clinical trial, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 10,040,000
- Enrollment target
NCT07308704 is a clinical trial that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 10,040,000 participants.
The verdict
NCT07308704 is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 10,040,000 participants
- Enrollment target
Study Summary
The purpose of this study is to deploy and evaluate informational AI-Echo algorithms that assist echo clinicians in interpreting core echocardiographic parameters (e.g., LV/RV size and function, valvular disease severity) and stratifying disease progression risk. The primary outcome is clinician usability, interpretive consistency, and workflow integration. Second, we will conduct a pragmatic, stepped-wedge clinical trial with multiple arms evaluating diagnostic AI-Echo algorithms designed to identify specific cardiovascular diseases- such as genetic cardiomyopathy, ischemic heart disease, and cardiac amyloidosis-and assess whether AI deployment increases diagnostic testing and shortens time to diagnosis. Trials will be conducted using EHR-based notification systems with cluster-level randomization.
Interventions
- DIAGNOSTIC_TEST Transthoracic Echocardiography (TTE)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,040,000 participants |
| Start Date | 2026-02-26 |
| Est. Completion | 2028-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07308704
The ClinicalTrials.gov registry entry for NCT07308704 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,040,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transthoracic Echocardiography (TTE) is the first listed.
NCT07308704 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07308704 about?
NCT07308704 is a clinical study titled "A Study Of Deep Learning For Echo Analysis, Tracking, And Evaluation". The purpose of this study is to deploy and evaluate informational AI-Echo algorithms that assist echo clinicians in interpreting core echocardiographic parameters (e.g., LV/RV size and function, valvular disease severity) and stratifying disease progression risk. The primary outcome is clinician usa...
What is the current status of trial NCT07308704?
This trial is currently recruiting. The enrollment target is 10,040,000 participants. The study started on 2026-02-26. Estimated completion is 2028-02.
What interventions are being tested in trial NCT07308704?
The interventions under investigation include: Transthoracic Echocardiography (TTE) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07308704?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.